Efficacy of a Low-Cost, Heat-Stable Oral Rotavirus Vaccine in Niger.
PubWeight™: 3.22‹?›
| Rank: Top 1%
Published in N Engl J Med on April 28, 2017
Authors
Sheila Isanaka1, Ousmane Guindo1, Celine Langendorf1, Amadou Matar Seck1, Brian D Plikaytis1, Nathan Sayinzoga-Makombe1, Monica M McNeal1, Nicole Meyer1, Eric Adehossi1, Ali Djibo1, Bruno Jochum1, Rebecca F Grais1
Author Affiliations
1: From the Department of Research, Epicentre, Paris (S.I., C.L., R.F.G.); the Departments of Nutrition and Global Health and Population, Harvard T.H. Chan School of Public Health, Boston (S.I.); Epicentre (O.G., A.M.S., N.S.-M.), National Hospital (E.A.), and University of Niamey (A.D.), Niamey, Niger; BioStat Consulting, Jasper, GA (B.D.P.); Laboratory of Specialized Clinical Studies, Cincinnati Children's Hospital Medical Center, Cincinnati (M.M.M., N.M.); and Médecins sans Frontières Operational Center, Geneva (B.J.).